A detailed history of Hazlett, Burt & Watson, Inc. transactions in Edwards Lifesciences Corp stock. As of the latest transaction made, Hazlett, Burt & Watson, Inc. holds 141 shares of EW stock, worth $9,554. This represents 0.0% of its overall portfolio holdings.

Number of Shares
141
Previous 141 -0.0%
Holding current value
$9,554
Previous $13,000 30.77%
% of portfolio
0.0%
Previous 0.01%

Shares

5 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q1 2024

Apr 29, 2024

SELL
$72.54 - $95.56 $40,912 - $53,895
-564 Reduced 80.0%
141 $13,000
Q2 2023

Aug 01, 2023

SELL
$81.41 - $94.33 $43,961 - $50,938
-540 Reduced 43.37%
705 $66,000
Q4 2022

Jan 25, 2023

SELL
$68.3 - $87.44 $2,458 - $3,147
-36 Reduced 2.81%
1,245 $93,000
Q3 2022

Oct 20, 2022

SELL
$82.37 - $107.29 $17,544 - $22,852
-213 Reduced 14.26%
1,281 $106,000
Q1 2022

May 05, 2022

BUY
$101.96 - $128.34 $152,328 - $191,739
1,494 New
1,494 $176,000

Others Institutions Holding EW

About Edwards Lifesciences Corp


  • Ticker EW
  • Exchange NYSE
  • Sector Healthcare
  • Industry Medical Devices
  • Shares Outstandng 618,259,968
  • Market Cap $41.9B
  • Description
  • Edwards Lifesciences Corporation provides products and technologies for structural heart disease, and critical care and surgical monitoring in the United States, Europe, Japan, and internationally. It offers transcatheter heart valve replacement products for the minimally invasive replacement of heart valves; and transcatheter heart valve repair...
More about EW
Track This Portfolio

Track Hazlett, Burt & Watson, Inc. Portfolio

Follow Hazlett, Burt & Watson, Inc. and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Hazlett, Burt & Watson, Inc., based on Form 13F filings with the SEC.

News

Stay updated on Hazlett, Burt & Watson, Inc. with notifications on news.